272 related articles for article (PubMed ID: 16282216)
1. Willingness to pay per quality-adjusted life year in a study of knee osteoarthritis.
Byrne MM; O'malley K; Suarez-Almazor ME
Med Decis Making; 2005; 25(6):655-66. PubMed ID: 16282216
[TBL] [Abstract][Full Text] [Related]
2. Willingness to pay for a quality-adjusted life year: implications for societal health care resource allocation.
King JT; Tsevat J; Lave JR; Roberts MS
Med Decis Making; 2005; 25(6):667-77. PubMed ID: 16282217
[TBL] [Abstract][Full Text] [Related]
3. Willingness to pay for a QALY.
Gyrd-Hansen D
Health Econ; 2003 Dec; 12(12):1049-60. PubMed ID: 14673813
[TBL] [Abstract][Full Text] [Related]
4. Quality-adjusted life years was a poor predictor of women's willingness to pay in acute and chronic conditions: results of a survey.
Franic DM; Pathak DS; Gafni A
J Clin Epidemiol; 2005 Mar; 58(3):291-303. PubMed ID: 15718119
[TBL] [Abstract][Full Text] [Related]
5. Do utility values and willingness to pay suitably reflect health outcome in hip and knee osteoarthritis? A comparative analysis with the WOMAC Index.
Ethgen O; Tancredi A; Lejeune E; Kvasz A; Zegels B; Reginster JY
J Rheumatol; 2003 Nov; 30(11):2452-9. PubMed ID: 14677192
[TBL] [Abstract][Full Text] [Related]
6. Estimating a WTP-based value of a QALY: the 'chained' approach.
Robinson A; Gyrd-Hansen D; Bacon P; Baker R; Pennington M; Donaldson C;
Soc Sci Med; 2013 Sep; 92():92-104. PubMed ID: 23849283
[TBL] [Abstract][Full Text] [Related]
7. A welfare economic approach to measure outcomes in stuttering: comparing willingness to pay and quality adjusted life years.
Franic DM; Bothe AK; Bramlett RE
J Fluency Disord; 2012 Dec; 37(4):300-13. PubMed ID: 23218213
[TBL] [Abstract][Full Text] [Related]
8. GET MORE, PAY MORE? An elaborate test of construct validity of willingness to pay per QALY estimates obtained through contingent valuation.
Bobinac A; van Exel NJ; Rutten FF; Brouwer WB
J Health Econ; 2012 Jan; 31(1):158-68. PubMed ID: 22018622
[TBL] [Abstract][Full Text] [Related]
9. Valuing avoided morbidity using meta-regression analysis: what can health status measures and QALYs tell us about WTP?
Van Houtven G; Powers J; Jessup A; Yang JC
Health Econ; 2006 Aug; 15(8):775-95. PubMed ID: 16544361
[TBL] [Abstract][Full Text] [Related]
10. International survey on willingness-to-pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness?
Shiroiwa T; Sung YK; Fukuda T; Lang HC; Bae SC; Tsutani K
Health Econ; 2010 Apr; 19(4):422-37. PubMed ID: 19382128
[TBL] [Abstract][Full Text] [Related]
11. Willingness to pay for a QALY based on community member and patient preferences for temporary health states associated with herpes zoster.
Lieu TA; Ray GT; Ortega-Sanchez IR; Kleinman K; Rusinak D; Prosser LA
Pharmacoeconomics; 2009; 27(12):1005-16. PubMed ID: 19908925
[TBL] [Abstract][Full Text] [Related]
12. [Economic examination of the 2006/7 update of the Israeli national list of health services].
Shmueli A; Nissan-Englcin E
Harefuah; 2008 Jun; 147(6):488-92, 576. PubMed ID: 18693622
[TBL] [Abstract][Full Text] [Related]
13. A utility-theoretic model for QALYs and willingness to pay.
Klose T
Health Econ; 2003 Jan; 12(1):17-31. PubMed ID: 12483758
[TBL] [Abstract][Full Text] [Related]
14. Can we estimate the 'social' value of a QALY? Four core issues to resolve.
Smith RD; Richardson J
Health Policy; 2005 Sep; 74(1):77-84. PubMed ID: 16098414
[TBL] [Abstract][Full Text] [Related]
15. What does the value of modern medicine say about the $50,000 per quality-adjusted life-year decision rule?
Braithwaite RS; Meltzer DO; King JT; Leslie D; Roberts MS
Med Care; 2008 Apr; 46(4):349-56. PubMed ID: 18362813
[TBL] [Abstract][Full Text] [Related]
16. Willingness to pay per quality-adjusted life year: is one threshold enough for decision-making?: results from a study in patients with chronic prostatitis.
Zhao FL; Yue M; Yang H; Wang T; Wu JH; Li SC
Med Care; 2011 Mar; 49(3):267-72. PubMed ID: 21224742
[TBL] [Abstract][Full Text] [Related]
17. Relationship between utility values and willingness to pay in patients undergoing orthognathic treatment.
Cunningham SJ; Hunt NP
Community Dent Health; 2000 Jun; 17(2):92-6. PubMed ID: 11349993
[TBL] [Abstract][Full Text] [Related]
18. Willingness to pay for a quality-adjusted life-year: the individual perspective.
Bobinac A; Van Exel NJ; Rutten FF; Brouwer WB
Value Health; 2010 Dec; 13(8):1046-55. PubMed ID: 20825620
[TBL] [Abstract][Full Text] [Related]
19. Willingness-to-pay stated preferences for 8 health-related quality-of-life domains in psoriatic arthritis: a pilot study.
Hu SW; Holt EW; Husni ME; Qureshi AA
Semin Arthritis Rheum; 2010 Apr; 39(5):384-97. PubMed ID: 19095293
[TBL] [Abstract][Full Text] [Related]
20. Valuing a hypothetical cure for rheumatoid arthritis using the contingent valuation methodology: the patient perspective.
Fautrel B; Clarke AE; Guillemin F; Adam V; St-Pierre Y; Panaritis T; Fortin PR; Menard HA; Donaldson C; Penrod JR
J Rheumatol; 2005 Mar; 32(3):443-53. PubMed ID: 15742435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]